CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.

Difference between revisions of "User:Tomomi Sumida"

From CAZypedia
Jump to navigation Jump to search
(Created page with "200px|right '''This is an empty template to help you get started with composing your User page.''' You should begin by opening this page for ed...")
 
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
[[Image:Blank_user-200px.png|200px|right]]
+
[[Image:Tomomi Sumida.jpg|200px|right]]
'''This is an empty template to help you get started with composing your User page.'''
 
  
You should begin by opening this page for editing by clicking on the Edit tab above. Your biography goes in this area of the page.
+
Tomomi Sumida obtained her Ph.D. from [http://www.agr.kyushu-u.ac.jp/english/ the Department of Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyusyu University], under the supervision of Professor Makoto Ito in 2010. She isolated the ganglioside–degrading bacterium ''Paenibacillus'' sp. strain TS12 from land soil in her doctoral research <cite>SumidaAEM2002</cite>. Strain TS12 produces a series of glycosphingolipid-degrading enzymes, such as sialidase, β-galactosidase, β-hexosaminidase, β-''N''-acetylgalactosaminidase, and β-glucocerebrosidase. She has reported the molecular cloning, characterization, and structural analysis of these novel glycosphingolipid-degrading enzymes, as follows:
  
* See [[User:Gerlind_Sulzenbacher]] for an example. You may copy text from this example by opening the page in another browser window and clicking the "Edit" tab.
+
* [[GH3]] β-glucocerebrosidase (Glc4) from ''Paenibacillus'' sp. TS12 <cite>SumidaJB2002</cite>.
* Add your publications in the list below using PubMed IDs and cite them in the text like this <cite>Gilbert2008</cite>.
+
* [[GH20]] β-hexosaminidase (Hex1) from ''Paenibacillus'' sp. TS12 <cite>SumidaJMB2009 SumidaOBC2012</cite>.
* Please upload a picture of yourself using the "Upload file" link in the Toolbox section of the left menu, and then replace the Image filename with your own.
+
* [[GH123]] β-''N''-acetylgalactosaminidase (NgaP) from ''Paenibacillus'' sp. TS12 <cite>SumidaJBC2011</cite>.
  
''More specific help on these steps is available from the links under the "For contributors" section of the left page menu.''
+
NgaP, which specifically hydrolyzes the non-reducing terminal β-GalNAc linkage but not β-GlcNAc linkage, is the first β-''N''-acetylgalactosaminidase (EC 3.2.1.53) to have its primary structure elucidated. Since the primary structure of NgaP is totally new, [http://www.cazy.org/GH123.html GH123] was created as a new family of β-''N''-acetylgalactosaminidases in 2011.
  
  
Line 15: Line 14:
  
 
<biblio>
 
<biblio>
#Gilbert2008 pmid=18430603
+
#SumidaAEM2002 pmid=12406710
 +
#SumidaJB2002 pmid=12153721
 +
#SumidaJMB2009 pmid=19524595
 +
#SumidaOBC2012 pmid=22367352
 +
#SumidaJBC2011 pmid=21297160
  
</biblio>
+
</biblio>  
  
 
<!-- Do not remove this Category tag -->
 
<!-- Do not remove this Category tag -->
 
[[Category:Contributors|Sumida,Tomomi]]
 
[[Category:Contributors|Sumida,Tomomi]]

Latest revision as of 03:39, 11 August 2016

Tomomi Sumida.jpg

Tomomi Sumida obtained her Ph.D. from the Department of Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyusyu University, under the supervision of Professor Makoto Ito in 2010. She isolated the ganglioside–degrading bacterium Paenibacillus sp. strain TS12 from land soil in her doctoral research [1]. Strain TS12 produces a series of glycosphingolipid-degrading enzymes, such as sialidase, β-galactosidase, β-hexosaminidase, β-N-acetylgalactosaminidase, and β-glucocerebrosidase. She has reported the molecular cloning, characterization, and structural analysis of these novel glycosphingolipid-degrading enzymes, as follows:

  • GH3 β-glucocerebrosidase (Glc4) from Paenibacillus sp. TS12 [2].
  • GH20 β-hexosaminidase (Hex1) from Paenibacillus sp. TS12 [3, 4].
  • GH123 β-N-acetylgalactosaminidase (NgaP) from Paenibacillus sp. TS12 [5].

NgaP, which specifically hydrolyzes the non-reducing terminal β-GalNAc linkage but not β-GlcNAc linkage, is the first β-N-acetylgalactosaminidase (EC 3.2.1.53) to have its primary structure elucidated. Since the primary structure of NgaP is totally new, GH123 was created as a new family of β-N-acetylgalactosaminidases in 2011.



  1. Sumida T, Sueyoshi N, and Ito M. (2002). Utilization of ganglioside-degrading Paenibacillus sp. strain TS12 for production of glucosylceramide. Appl Environ Microbiol. 2002;68(11):5241-8. DOI:10.1128/AEM.68.11.5241-5248.2002 | PubMed ID:12406710 [SumidaAEM2002]
  2. Sumida T, Sueyoshi N, and Ito M. (2002). Molecular cloning and characterization of a novel glucocerebrosidase of Paenibacillus sp. TS12. J Biochem. 2002;132(2):237-43. DOI:10.1093/oxfordjournals.jbchem.a003216 | PubMed ID:12153721 [SumidaJB2002]
  3. Sumida T, Ishii R, Yanagisawa T, Yokoyama S, and Ito M. (2009). Molecular cloning and crystal structural analysis of a novel beta-N-acetylhexosaminidase from Paenibacillus sp. TS12 capable of degrading glycosphingolipids. J Mol Biol. 2009;392(1):87-99. DOI:10.1016/j.jmb.2009.06.025 | PubMed ID:19524595 [SumidaJMB2009]
  4. Sumida T, Stubbs KA, Ito M, and Yokoyama S. (2012). Gaining insight into the inhibition of glycoside hydrolase family 20 exo-β-N-acetylhexosaminidases using a structural approach. Org Biomol Chem. 2012;10(13):2607-12. DOI:10.1039/c2ob06636j | PubMed ID:22367352 [SumidaOBC2012]
  5. Sumida T, Fujimoto K, and Ito M. (2011). Molecular cloning and catalytic mechanism of a novel glycosphingolipid-degrading beta-N-acetylgalactosaminidase from Paenibacillus sp. TS12. J Biol Chem. 2011;286(16):14065-72. DOI:10.1074/jbc.M110.182592 | PubMed ID:21297160 [SumidaJBC2011]

All Medline abstracts: PubMed